Related Experiment Video

Updated: Jun 15, 2026

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
10:02

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

Published on: May 28, 2017

Testing the amyloid hypothesis of Alzheimer's disease in vivo

Sam Gandy

    The Lancet. Neurology
    |March 2, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
    09:33

    Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

    Published on: December 26, 2016

    Related Experiment Videos

    Last Updated: Jun 15, 2026

    Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
    10:02

    Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

    Published on: May 28, 2017

    Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
    09:33

    Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

    Published on: December 26, 2016

    Related Concept Videos

    Alzheimer's Disease: Overview01:26

    Alzheimer's Disease: Overview

    Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
    The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

    Articles linked to this work by shared authors, journal, and citation graph.

    Rapid plaque clearance with anti-amyloid therapy for Alzheimer's disease: in consideration of donanemab treatment duration from real-world cases.

    Neurocase·2026

    miR155, triplicated in Down syndrome, regulates the development of neural stem cells and GABAergic interneurons in Alzheimer's disease mouse and human iPSC models.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

    Molecular Networks and Key Regulators Underlying Resilience of the Human Brain to Aging and Dementia.

    Biomolecules·2026

    Endogenously generated Dutch-type Aβ non-fibrillar aggregates dysregulate presynaptic neurotransmission in the absence of detectable inflammation.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

    Real-world clinical profile of individuals with cerebrospinal fluid Aβ-/pTau181.

    Journal of Alzheimer's disease : JAD·2026

    Golgi Fragmentation as a Potential Link Between SARS-CoV-2 Infection and Alzheimer's Disease: Mechanisms and Implications for Neurodegeneration in Long COVID.

    Sub-cellular biochemistry·2026

    Plasma phosphorylated tau 217 concentrations, APOE genotype, and timing of cognitive impairment in individuals across diverse racial and ethnic groups: a pooled analysis of prospective cohort studies.

    The Lancet. Neurology·2026

    Clinical pathways for cognitively unimpaired individuals with Alzheimer's disease neuropathological change.

    The Lancet. Neurology·2026

    Neuroimaging in the era of biologically defined Alzheimer's disease and disease-modifying therapy.

    The Lancet. Neurology·2026

    Fluid biomarkers in the evolving care landscape of Alzheimer's disease and related disorders.

    The Lancet. Neurology·2026

    Safety, tolerability, and efficacy of RIPK1 inhibitor, SAR443820, in amyotrophic lateral sclerosis (HIMALAYA): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

    The Lancet. Neurology·2026

    Prevalence of unruptured intracranial aneurysms according to comorbidities, risk factors, country, and time period: a systematic review and meta-analysis.

    The Lancet. Neurology·2026

    Comparing the efficacy of first-line immunotherapies in autoimmune encephalitis: a scoping review.

    Frontiers in neurology·2026

    Herbal hot compress combined with bianstone warm ironing improves anxiety and cognitive impairment via gut-brain-HPA axis in pubertal mesenteric lymphadenitis rats.

    Frontiers in pediatrics·2026

    Elevated ALT correlates with severe liver injury, monocyte infiltration, and Pro-inflammatory immune dysregulation in chronic hepatitis B virus infection.

    Frontiers in medicine·2026

    Immunological dysregulation of follicular helper T cells, follicular regulatory T cells, and follicular cytotoxic T cells is associated with disease activity and identifies exploratory immune patterns in rheumatoid arthritis.

    Frontiers in immunology·2026

    Cryo-EM reveals patient- versus organ-specific structural diversity and bound ligands in λ6 light chain amyloids.

    bioRxiv : the preprint server for biology·2026

    Diagnostic performance of antibodies against extractable nuclear antigens detected by immunoblot in the differentiation of connective tissue diseases.

    Allergologia et immunopathologia·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us